Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Developing expertise and collaborations in COVID-19 to lead practice-changing trials.

The COVID-19 pandemic required a rapid response to understand the best ways of treating vulnerable patients. This led to an urgent need for researchers who had the right expertise to help deliver the necessary practice-changing clinical trials.  

SPCR’s funding helped to highlight Paul Little, professor of primary care research at the University of Southampton, as having a strong interest in the field and use his experience to help change the way we treat COVID-19.  

With a background in respiratory disease, it was natural for Paul to take an interest in COVID-19. He was a co-applicant on an SPCR-funded project with Professor Nick Francis in Southampton and Professor Chris Butler in Oxford, exploring the impact of over-the-counter treatments and health behaviours on the prevention of COVID-19 and outcomes, such as hospitalisation.